Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-28T09:24:05.684Z Has data issue: false hasContentIssue false
  • English
  • Français

Does nutrition have a role in peripheral vascular disease?

Published online by Cambridge University Press:  08 March 2007

Juan J. Carrero  and
Robert F. Grimble
Juan J. Carrero
Affiliation:
Department of Biochemistry and Molecular Biology, University of Granada, Spain
Robert F. Grimble*
Affiliation:
School of Medicine, University of Southampton, UK
*
*Corresponding author: fax +44 2380 594379, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Peripheral vascular disease (PVD) is a manifestation of systemic atherosclerosis in the lower limbs, and PVD patients have a 3- to 5-fold increased risk of cardiovascular mortality compared with age-matched controls. Nevertheless, recent reports show how PVD patients are undertreated with regard to CVD risk-factor reduction and the use of lipid-lowering or antiplatelet drugs. There is appreciable evidence that demonstrates the beneficial effects of certain nutrients and dietary habits in the prevention of CVD, but there has been little attention paid to the role of nutrients in PVD. The purpose of the present review is to provide an overview of our understanding of how foods could possibly benefit PVD. In the last few decades, several nutrients have arisen as potentially health-promoting in PVD. While nutritional interventions in PVD show positive clinical effects for fish oil, carnitine or vitamin E, others such as olive oil or vitamin C seem to interact only at a biochemical level by decreasing risk factors. Moreover, only epidemiological associations exist for the potential role of fibre, folates or vitamin B6 in this disease. In all cases, the limited data available provide no clear-cut evidence in favour of the clinical benefit of nutritional interventions aimed at reducing risk factors and ameliorating symptoms in PVD patients. No practical recommendations can be given at this stage, and further studies are clearly needed.

Keywords

Peripheral vascular diseaseFish oilOlive oilVitamin EVitamin C
Type
Review article
Information
British Journal of Nutrition , Volume 95 , Issue 2 , February 2006 , pp. 217 - 229
Copyright
Copyright © The Nutrition Society 2006

References

Alarcon de la Lastra, C, Barranco, MD, Motilva, V & Herrerias, JMMediterranean diet and health: biological importance of olive oil. Curr Pharm Des 2001 7, 933–950.CrossRefGoogle ScholarPubMed
Anonymous Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists’ Collaboration. BMJ 1998 316, 894–898.CrossRefGoogle Scholar
Anonymous Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC) Eur J Vasc Endovasc Surg 2000 19, S1–S250.Google Scholar
SJ, Bakker, Ijzerman, RG, Teerlink, T, Westerhoff, HV, Gans, RO & Heine, RJCytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure?“ Atherosclerosis 2000 148 17–21.Google Scholar
Barker, GA, Green, S, Askew, CD, Green, AA & Walker, PJEffect of propionyl-L-carnitine on exercise performance in peripheral arterial disease. Med Sci Sports Exerc 2001 33 1415–1422.CrossRefGoogle ScholarPubMed
Bauer, USix-month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency Arzneimittelforsschung 1984 34 716– 720.Google Scholar
Bazzano, LA, He, J, Ogden, LG, Loria, CM & Whelton, PKDietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 2003 163, 1897–1904.CrossRefGoogle ScholarPubMed
Blann, AD, Amiral, J, McCollum, CN & Lip, GYDifferences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls Atherosclerosis 2000a 152 29–34.CrossRefGoogle ScholarPubMed
Blann, AD, Farrell, A, Picton, A & McCollum, CNRelationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. Thromb Res 2000b 97, 209–216.CrossRefGoogle ScholarPubMed
Blann, AD, Seigneur, M, Steiner, M, Boisseau, MR & McCollum, CNCirculating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997 27, 916–921.CrossRefGoogle Scholar
Blume, J, Kieser, M & Hülscher, UPlacebo-controlled, doubleblind study on the efficacy of Ginkgo biloba special extract EGb 761 in maximum-level trained patients with intermittent claudication. Vasa 1996 25, 265–274.Google Scholar
Blume, J, Kieser, M & Hülscher, UEfficacy of Ginkgo biloba special extract EGb 761 in peripheral occlusive disease Fortschr Med 1998 116, 137–143.Google Scholar
Boers, GHHyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance Thromb Haemost 1997 78, 520–522.Google ScholarPubMed
Boger, RH, Bode-Boger, SM, Thiele, W, Creutzig, A, Alexander, K & Frolich, JCRestoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 1998 32, 1336–1344.CrossRefGoogle ScholarPubMed
Boyd, AM & Marks, JTreatment of intermittent claudication. A reappraisal of alpha-tocopherol Angiology 1963 14, 198–208.CrossRefGoogle ScholarPubMed
Brevetti, G, Chiariello, M, Ferulano, G, Policicchio, A, Nevola, E, Rossini, A, Ambrosio, G, Siliprandi, N & Angelini, CIncreases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study Circulation 1998a 77,767–773.CrossRefGoogle Scholar
Brevetti, G, Diehm, C & Lambert, DEuropean multicenter study on propionyl-L-carnitine in intermittent claudication J Am Coll Cardiol 1999 34, 1618–1624.CrossRefGoogle ScholarPubMed
Brevetti, G, Martone, VD, Perna, S, Cacciatore, F, Corrado, S, DiDonato, A & Di Iorio, AIntermittent claudication and risk of cardiovascular events. Angiology 1998b 49, 843–848.Google ScholarPubMed
Brevetti, G, Perna, S, Sabba, C, Martone, VD, Di Iorio, A &Barletta, GEffect of propionyl-L-carnitine on quality of life in intermittent claudication Am J Cardiol 1997 79, 777–780.CrossRefGoogle ScholarPubMed
Brevetti, G, Silvestro, A, Di Giacomo, S, Bucar, R, Di Donato, A, Schiano, V & Scopacasa, FEndothelial dysfunction in peripheral arterial disease is related to increased plasma markers of inflammation and severity of peripheral circulatory impairment, but not to classic risk factors and atherosclerotic burden. J Vasc Surg 2003 38, 374–379.CrossRefGoogle Scholar
Bronstrup, A, Hages, M, Prinz-Langenohl, R & Pietrzik, KEffects of folic acid and combinations of folic acid and vitamin B-12 on plasma homocysteine concentrations in healthy, young women. Am J Clin Nutr 1998 68, 1104–1110.CrossRefGoogle ScholarPubMed
Calder, PCn-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored Clin Sci (Lond) 2004 107, 1–11.CrossRefGoogle ScholarPubMed
Camargo, CA, Stampfer, MJ, Glynn, RJ, Gaziano, JM, Manson, JE, Goldhaber, SZ & Hennekens, CHProspective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians Circulation 1997 95, 577–580.CrossRefGoogle ScholarPubMed
Carrero, JJ, Fonolla, J, González-Santiago, M, Baro, L, Jimenez, J, Boza, J & Lopez-Huertas, EHealth effects due to folic acid supplementation. Food fortification strategies to achieve adequate folate status Nutrafoods 2004a 3, 5–13.Google Scholar
Carrero, JJ, Lopez-Huertas, E, Salmeron, LM, Baro, L & Ros, EDaily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with peripheral vascular disease. J Nutr 2005a 135, 1393–1399.CrossRefGoogle Scholar
Carrero, JJ, Madden, J, Hadley, Jet al..Fish oil alters the balance between LPS stimulated leukotriene B4 and prostaglandin E2 production by PBMCs in patients with peripheral vascular disease but not in healthy controls Clin Nutr 2004b 23, 789–790.Google Scholar
Carrero, JJ, Martin-Bautista, E, Baro, L, Fonolla, J, Jimenez, J, Boza, JJ & López-Huertas, ECardiovascular effects of omega-3 fatty acids and alternatives to increase intake. Nutr Hosp 2005b 20, 56–62.Google Scholar
Cassar, K, Coull, R, Bachoo, P, Macaulay, E & Brittenden, JManagement of secondary risk factors in patients with intermittent claudication Eur J Vasc Endovasc Surg 2003 26, 262–266.CrossRefGoogle ScholarPubMed
Cheng, SW, Ting, AC & Wong, JFasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg 1997 11, 217–223.CrossRefGoogle ScholarPubMed
Ciccarone, E, Di Castelnuovo, A, Assanelli, D, Archetti, S, Ruggeri, G, Salcuni, N, Donati, MB, Capani, F, Laciovalli, L & GENDIABE, InvestigatorsHomocysteine levels are associated with the severity of peripheral arterial disease in type 2 diabetic patients. J Thromb Haemost 2003 1, 2540–2547.CrossRefGoogle ScholarPubMed
Cleophas, TJ, Hornstra, N, van Hoogstraten, B & van der Meulen, JHomocysteine, a risk factor for coronary artery disease or not? A meta-analysis. Am J Cardiol 2000 86, 1005–1009.CrossRefGoogle ScholarPubMed
Criqui, MH, Langer, RD, Fronek, A, Feigelson, HS, Klauber, MR, McCann, TJ & Browner, DMortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992 326, 381–386.CrossRefGoogle Scholar
Dal Lago, A, De Martini, D, Flore, Ret al.. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial. Drugs Exp Clin Res 1999 25, 29–36.Google ScholarPubMed
de Jong, SC, Stehouwer, CD, van den Berg, M, Geurts, TW, Bouter, LM & Rauwerda, JANormohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study. J Intern Med 1999 246, 87–96.CrossRefGoogle ScholarPubMed
de Vriese, AS, Blom, HJ, Heil, SG, Mortier, S, Kluijtmans, LA, Van de Voorde, J & Lameire, NHEndothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia. Circulation 2004 109, 2331–2336.CrossRefGoogle ScholarPubMed
Diehr, P & Beresford, SAThe relation of dietary patterns to future survival, health, and cardiovascular events in older adults. J Clin Epidemiol 2003 56, 1224–1235.CrossRefGoogle ScholarPubMed
Djousse, L, Levy, D, Murabito, JM, Cupples, LA & Ellison, RCAlcohol consumption and risk of intermittent claudication in the Framingham Heart Study.. Circulation 2000 102, 3092–3097.CrossRefGoogle ScholarPubMed
Donnan, PT, Thomson, M, Fowkes, FG, Prescott, RJ & Housley, EDiet as a risk factor for peripheral arterial disease in the general population: the Edinburgh Artery Study. Am J Clin Nutr 1993 57, 917–921.CrossRefGoogle ScholarPubMed
Drexel, H, Steurer, J, Muntwyler, J, Meienberg, S, Schmid, HR, Schneider, E, Grochenig, E & Amann, FWPredictors of the presence and extent of peripheral arterial occlusive disease. Circulation 1996 94, 199–205.Google ScholarPubMed
Drossos, GE, Toumpoulis, IK, Katritsis, DG, Ioannidis, JP, Kontogiorgi, P, Svarna, E & Anagnostopoulos, CEIs vitamin C superior to diltiazem for radial artery vasodilation in patients awaiting coronary artery bypass grafting?“. J Thorac Cardiovasc SurgJ Thorac Cardiovasc SurgJ Thorac Cardiovasc SurgJ Thorac Cardiovasc Surg 2003 125, 330–335.Google ScholarPubMed
Duthie, GC, Wahle, KWJ & James, PWTOxidants, antioxidants and cardiovascular disease. Nutr Res Rev 1989 2, 51–62.CrossRefGoogle ScholarPubMed
Ernst, EEffects of n-3 fatty acids on blood rheology. J Intern Med 1989 225, Suppl., 129–132.CrossRefGoogle Scholar
Farrell, PM, Bieri, JG, Fratantoni, JF, Wood, RE & di Sant“Agnese, PAThe occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis J Clin Invest 1977 60, 233–241.CrossRefGoogle ScholarPubMed
Ferrara, LA, Raimondi, AS, d“Episcopo, L, Guida, L, Dello Russo, A & Marotta, TOlive oil and reduced need for antihypertensive medications Arch Intern Med 2000 160, 837–842.CrossRefGoogle ScholarPubMed
Ferrari, R, Visioli, O, Guarnieri, C & Caldarera, MVitamin E and the heart: possible role as antioxidant Acta Vitaminol Enzymol 1983 5, 11–22.Google ScholarPubMed
Fowkes, FG, Housley, E, Riemersma, RA, Macintyre, CC, Cawood, EH, Prescott, RJ & Ruckley, CVSmoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study Am J Epidemiol 1992 135, 331–340.CrossRefGoogle ScholarPubMed
Frankel, EN, Kanner, J, German, JB, Parks, E & Kinsella, JEInhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine Lancet 1993 341, 454–457.CrossRefGoogle ScholarPubMed
Gans, RO, Bilo, HJ, Weersink, EG, Rauwerda, JA, Fonk, T, Popp-Snijders, C & Donker, AJFish oil supplementation in patients with stable claudication. Am J Surg 1990 160, 490–495.CrossRefGoogle ScholarPubMed
Gokce, N, Keaney, JF Jr., Hunter, LM, WAtkins, MT, Nedelijkovic, ZS, Menzoian, JO & Vita, JAPredictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003 41, 1769–1775.CrossRefGoogle ScholarPubMed
Gorinstein, S, Zemser, M, Berliner, M, Goldstein, R, Libman, I, Trakhtenberg, S & Caspi, AModerate beer consumption and positive biochemical changes in patients with coronary atherosclerosis. J Intern Med 1997 242, 219–224.CrossRefGoogle ScholarPubMed
Graham, IM, Daly, LE, Refsum, HMet al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997 277, 1775–1781.CrossRefGoogle ScholarPubMed
Grimble, RF, Howell, WM, O’Reilly, G, Turner, SJ, Markovic, O, Hirrell, s, East, JM & Calder, PCThe ability of fish oil to suppress tumor necrosis factor-alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes which influence TNF-alpha production. Am J Clin Nutr 2002 76, 454–459.CrossRefGoogle Scholar
Haeger, KLong-time treatment of intermittent claudication with vitamin E. Am J Clin Nutr 1974 27, 1179–1181.CrossRefGoogle ScholarPubMed
Halperin, JLEvaluation of patients with peripheral vascular disease. Thrombosis Research 2002 106, 303–311.CrossRefGoogle ScholarPubMed
Hamilton, M, Wilson, GM, Armitage, P & Boyd, JTThe treatment of intermittent claudication with vitamin E. Lancet 1953 i, 367–370.CrossRefGoogle Scholar
Henke, PK, Blackburn, S, Proctor, MC, Stevens, J, Mukherjee, D, Rajagopalin, S, Upchurch, GR Jr., Stanley, JC & Eagle, KAPatients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 2004 39, 357–365.CrossRefGoogle ScholarPubMed
Hertzer, NRThe natural history of peripheral vascular disease: implications for its management. Circulation 1991 83, 12–19.Google ScholarPubMed
Hiatt, WRMedical treatment of the patient with intermittent claudication. J Vasc Tech 1994 18, 311–315.Google Scholar
Hiatt, WRMedical treatment of peripheral arterial disease and claudication. N Engl J Med 2001 344, 1608–1621.CrossRefGoogle ScholarPubMed
Hiatt, WR, Hoag, S & Hamman, RFEffect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley Diabetes Study. Circulation 1995 91, 1472–1479.CrossRefGoogle ScholarPubMed
Hirsch, AT & Hiatt, WRPARTNERS Steering Committee PAD awareness, risk, and treatment: new resources for survival – the USA PARTNERS program. Vasc Med 2001 6, 9–12.CrossRefGoogle Scholar
Ho, M, Maple, C, Bancroft, A, McLaren, M & Belch, JJThe beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology. Prostaglandins Leukot Essent Fatty Acids 1999 61, 13–17.CrossRefGoogle ScholarPubMed
Hooper, L, Griffiths, E, Abrahams, Bet al.. Dietetic guidelines: diet in secondary prevention of cardiovascular disease (first update June 2003). J Hum Nutr Diet 2004 17, 337–349.CrossRefGoogle ScholarPubMed
Hunninghake, DB, Miller, VT, LaRosa, JC, Kinosian, B, Brown, V, Howard, WJ, DiSerio, FJ & O’Connor, RRHypocholesterolemic effects of a dietary fibre supplement. Am J Clin Nutr 1994 59, 1050–1054.CrossRefGoogle Scholar
James, SL, Muir, JG, Curtis, SL & Gibson, PRDietary fibre: a roughage guide. Intern Med J 2003 33, 291–296.CrossRefGoogle ScholarPubMed
Jenkins, DJ, Axelsen, M, Kendall, CW, Augustin, LS, Vuksan, V & Smithe, UDietary fibre, lente carbohydrates and the insulin-resistant diseases. Br J Nutr 2000 83, 157–163.CrossRefGoogle ScholarPubMed
Jenkins, DJ & Jenkins, ALDietary fibre and the glycemic response. Proc Soc Exp Biol Med 1985 180, 422–431.CrossRefGoogle ScholarPubMed
Jepson, RG, Fowkes, FG, Donnan, PT & Housley, EAlcohol intake as a risk factor for peripheral arterial disease in the general population in the Edinburgh Artery Study. Eur J Epidemiol 1995 11, 9–14.CrossRefGoogle ScholarPubMed
Jepson, RGKleijnen, J & Leng, GCIn The Cochrane Library Garlic for peripheral arterial occlusive disease (Cochrane Review). issue 3. Chichester, UKJohn Wiley & Sons, Ltd. 2005Google Scholar
Jeukendrup, AERegulation of fat metabolism in skeletal muscle. Ann N Y Acad Sci 2002 967, 217–235.CrossRefGoogle ScholarPubMed
Kanayasu-Toyoda, T, Morita, I, Hibino, H, Nakao-Hayashi, JIto, H & Murota, SEicosapentaenoic acid abolishes the proatherogenic effects of cholesterol: effects on migration of bovine smooth muscle and endothelial cells in vitro. Prostaglandins Leukot Essent Fatty Acids 1993 48, 463–468.CrossRefGoogle ScholarPubMed
Kanayasu-Toyoda, T, Morita, I & Murota, SDocosapentaenoic acid (22: 5, n-3), an elongation metabolite of eicosapentaenoic acid (20: 5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostaglandins Leukot Essent Fatty Acids 1996 54, 319–325.CrossRefGoogle ScholarPubMed
Karlic, H & Lohninger, ASupplementation of L-carnitine in athletes: does it make sense?“. Nutrition 2004 20, 709–715.CrossRefGoogle ScholarPubMed
Katsouyanni, K, Skalkidis, Y, Petridou, E, Polychronopoulou-Trichopoulou, A, Willett, W & Trichopoulos, DDiet and peripheral arterial occlusive disease: the role of poly-, mono-, and saturated fatty acids. Am J Epidemiol 1991 133, 24–31.CrossRefGoogle ScholarPubMed
Kearns, SR, Daly, AF, Sheehan, K, Murray, P, Kelly, C & Bouchier-Hayes, DOral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome. J Bone Joint Surg Br 2004 89, 906–911.CrossRefGoogle Scholar
Khaira, HS, Maxwell, SR & Shearman, CPAntioxidant consumption during exercise in intermittent claudication. Br J Surg 1995 82, 1660–1662.CrossRefGoogle ScholarPubMed
Khaira, HS, Maxwell, SR, Thomason, H, Thorpe, GH, Green, MA & Shearman, CPAntioxidant depletion during aortic aneurysm repair. Br J Surg 1996 83, 401–403.CrossRefGoogle ScholarPubMed
Kiesewetter, H, Jung, F, Jung, EM, Blume, J, Mrowietz, C, Birk, A, Koscielny, J & Wenzel, EEffects of garlic coated tablets in peripheral arterial occlusive disease. Clin Investig 1993 71, 383–386.CrossRefGoogle ScholarPubMed
King, DE, Egan, BM & Geesey, MERelation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 2003 92, 1335–1339.CrossRefGoogle ScholarPubMed
Kinlay, S, Behrendt, D, Fang, JC, Delegrange, D, Morrow, J, Witztum, JL, Rifai, N, Selwyn, NP, Creager, MA & Ganz, PLong-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 2004 43, 629–634.CrossRefGoogle Scholar
Kleijnen, J & Knipschild, PGinkgo biloba. Lancet 1992 340, 1136–1139.CrossRefGoogle ScholarPubMed
Kleijnen, J & Mackerras, DIn The Cochrane Library, Vitamin E for intermittent claudication (Cochrane Review). issue 3. Chichester, UK: John Wiley & Sons, Ltd. 2004Google Scholar
Klipstein-Grobusch, K, den Breeijen, JH, Grobbee, DE, Boeing, H, Hofman, A & Witteman, JCDietary antioxidants and peripheral arterial disease: the Rotterdam Study. Am J Epidemiol 2001 154, 145–149.CrossRefGoogle ScholarPubMed
Koga, T, Claycombe, K & Meydani, MHomocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 2002 161, 365–374.CrossRefGoogle ScholarPubMed
Kuan, YM, E Dear, A & Grigg, MJHomocysteine: an aetiological contributor to peripheral vascular arterial disease. ANZ J Surg 2002 72, 668–671CrossRefGoogle ScholarPubMed
Langlois, M, Duprez, D, Delanghe, J, De Buyzere, M & Clement, DLSerum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001 103, 1863–1868.CrossRefGoogle ScholarPubMed
Leng, GC & Fowkes, FGRThe epidemiology of peripheral arterial disease. Vasc Med Rev 1993 4, 5–18.CrossRefGoogle Scholar
Leng, GC, Fowkes, FG, Lee, AJ, Dunbar, J, Housley, E & Ruckley, CVUse of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996 313, 1440–1444.CrossRefGoogle ScholarPubMed
Leng, GC, Lee, AJ, Fowkes, FG, Jepson, RG, Lowe, GD, Skinner, ER & Mowat, BFRandomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin Nutr 1998 17, 265–271.CrossRefGoogle ScholarPubMed
Lentz, SR & Sadler, JEInhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991 88, 1906–1914.CrossRefGoogle Scholar
Liese, AD, Roach, AK, Sparks, KC, Marquart, L, D’Agostino, RB Jr & Mayer-Davis, EJWhole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Am J Clin Nutr 2003 78, 965–971.CrossRefGoogle ScholarPubMed
Livingstone, PD & Jones, CTreatment of intermittent claudication with vitamin E. Lancet 1958 ii, 602–664.CrossRefGoogle Scholar
Lowe, GD, Fowkes, FG, Dawes, J, Donnan, PT, Lennie, SE & Housley, EBlood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993 87, 1915–1920.CrossRefGoogle ScholarPubMed
McDermott, MM, Mehta, S, Ahn, H & Greenland, PAtherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997 12, 209–215.CrossRefGoogle ScholarPubMed
Marckmann, P, Sandstrom, B & Jespersen, JDietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis 1993 101, 225–234.CrossRefGoogle ScholarPubMed
Markovic, O, O’Reilly, G, Fussell, HM, Turner, SJ, Calder, PC, Howell, WM & Grimble, RFRole of single nucleotide polymorphisms of proinflammatory cytokine genes on the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males. Clin Nutr 2004 23, 1084–1095.CrossRefGoogle ScholarPubMed
Maxwell, AJ, Anderson, BE & Cooke, JPNutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med 2000 5, 11–19.Google ScholarPubMed
Mennen, LI, Balkau, B, Vol, S, Caces, E & Eschwege, EFibrinogen: a possible link between alcohol consumption and cardiovascular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol 1999 19, 887–892.CrossRefGoogle ScholarPubMed
Merchant, AT, Hu, FB, Spiegelman, D, Willett, WC, Rimm, EB & Ascherio, AThe use of B vitamin supplements and peripheral arterial disease risk in men are inversely related. J Nutr 2003a 133, 2863–2867.CrossRefGoogle ScholarPubMed
Merchant, AT, Hu, FB, Spiegelman, D, Willett, WC, Rimm, EB & Ascherio, ADietary fibre reduces peripheral arterial disease risk in men. J Nutr 2003a 133, 3658–3663.CrossRefGoogle ScholarPubMed
Meydani, M, Natiello, F, Goldin, B, Free, N, Wood, M, Schaefer, E, Blumberg, JB & Gorbach, SLEffect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J Nutr 1991 121, 484–491.CrossRefGoogle ScholarPubMed
Mori, TA, Vandongen, R, Mahanian, F & Douglas, APlasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation. Metabolism 1992 41, 1059–1067.CrossRefGoogle ScholarPubMed
Morrissey, PA & Sheehy, PJOptimal nutrition: vitamin E. Proc Nutr Soc 1999 58, 459–468.CrossRefGoogle ScholarPubMed
Mujumdar, VS, Aru, GM & Tyagi, SCInduction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 2001 82, 491–500.CrossRefGoogle ScholarPubMed
Mukherjee, D, Lingam, P, Chetcuti, S, Grossman, PM, Moscucci, M, Luciano, AE & Eagle, KAMissed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative, (PVD-QI2). Circulation 2002 106, 1909–1912.CrossRefGoogle ScholarPubMed
Muluk, SC, Muluk, VS, Kelley, ME, Whittle, JC, Tierney, JA, Webster, MW & Makaroun, MSOutcome events in patients with claudication: a 15-years study in 2777 patients. J Vasc Surg 2001 33, 251–257.CrossRefGoogle Scholar
Nappo, F, De Rosa, N, Marfella, R, De Lucia, D, Ingrosso, D, Perna, AF, Farzati, B & Giugliano, DImpairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999 281, 2113–2118.CrossRefGoogle ScholarPubMed
National Cholesterol Education Programme Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Washington, DC: NIH. National Institutes of Health publication number 02–5215 2002Google Scholar
Pereira, MA, O’Reilly, E, Augustsson, Ket al.. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 2004 164, 370–376.CrossRefGoogle ScholarPubMed
Peters, H, Kieser, M & Hölscher, UDemonstration of the efficacy of Ginkgo biloba special extract EGb 761(R) on intermittent claudication: a placebo-controlled, double-blind multicenter trial. VASA 1998 27, 106–110.Google Scholar
Philipp, CS, Cisar, LA, Kim, HC, Wilson, AC, Saidi, P & Kostis, JBAssociation of hemostatic factors with peripheral vascular disease. Am Heart J 1997 134, 978–984.CrossRefGoogle ScholarPubMed
Piesse, JWVitamin E and peripheral vascular disease Int Clin Nutr Rev 1984 4, 178–182.Google Scholar
Pittler, MH & Ernst, EGinkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000 108, 276–281.CrossRefGoogle ScholarPubMed
Podmore, ID, Griffiths, HR, Herbert, KE, Mistry, N, Mistry, P & Lunec, JVitamin C exhibits pro-oxidant properties Nature 1998 392, 559.CrossRefGoogle ScholarPubMed
Poredos, P, Golob, M & Jensterle, MInterrelationship between peripheral arterial occlusive disease, carotid atherosclerosis and flow mediated dilation of the brachial artery. Int Angiol 2003 22, 83–87.Google ScholarPubMed
Ramirez-Tortosa, C, Lopez-Pedrosa, JM, Suarez, A, Ros, E, Mataix, J & Gil, AOlive oil- and fish oil-enriched diets modify plasma lipids and susceptibility of LDL to oxidative modification in freeliving male patients with peripheral vascular disease: the Spanish Nutrition Study. Br J Nutr 1999a 82, 31–39.CrossRefGoogle ScholarPubMed
Ramirez-Tortosa, MC, Urbano, G, Lopez-Jurado, M, Nestares, T, Gomez, MC, Mir, A, Ros, E, Mataix, J & Gil, AExtravirgin olive oil increases the resistance of LDL to oxidation more than refined olive oil in free-living men with peripheral vascular disease. J Nutr 1999b 129, 2177–2183.CrossRefGoogle ScholarPubMed
Refsum, H, Ueland, PM, Nygard, O & Vollset, SEHomocysteine and cardiovascular disease. Annu Rev Med 1998 49, 31–62.CrossRefGoogle ScholarPubMed
Reichl, D & Miller, NEPathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 1989 9, 785–797.CrossRefGoogle ScholarPubMed
Renaud, SC & Ruf, JCEffects of alcohol on platelet functions. Clin Chim Acta 1996 246, 77–89.CrossRefGoogle ScholarPubMed
Riba, R, Nicolaou, A, Troxler, M, Homer-Vaniasinkam, S & Naseem, KMAltered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis 2004 175, 69–75.CrossRefGoogle ScholarPubMed
Ridker, PM, Vaughan, DE, Stampfer, MJ, Glynn, RJ & Hennekens, CHAssociation of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA 1994 272, 929–933.CrossRefGoogle ScholarPubMed
Rodgers, GM & Kane, WHActivation of endogenous factor V by homocysteine-induce vascular endothelial cell activator. J Clin Invest 1986 11, 19091916.CrossRefGoogle Scholar
Ross, RRelated atherosclerosis – an inflammatory disease. N Engl J Med 1999 340, 115126.CrossRefGoogle Scholar
Rossi, E, Biasucci, LM, Citterio, F, Pelliccioni, S, Monaco, C, Ginnetti, F, Angiolillo, DJ, Grieco, G, Liuzzo, G & Maseri, ARisk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 2002 105, 800–803.CrossRefGoogle ScholarPubMed
Ruiz-Gutierrez, V, Muriana, FJ, Guerrero, A, Cert, AM & Villar, JPlasma lipids, erythrocyte membrane lipids and blood pressure of hypertensive women after ingestion of dietary oleic acid from two different sources. J Hypertens 1996 14, 1483–1490.CrossRefGoogle ScholarPubMed
Schneider, BGinkgo biloba extract in peripheral arterial disease. Meta-analysis of controlled clinical trials. Arzneimittelforschung 1992 42, 428–436.Google Scholar
Schweizer, J & Hautmann, CComparison of two dosages of Ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine’s stage IIb. Arzneimittelforschung 1999 49, 900–904.Google ScholarPubMed
Shute, EV, Vogelsang, AB, Skelton, FR & Shute, WEThe influence of vitamin E on vascular disease. Surg Gynaecol Obst 1948 86, 1–8.Google ScholarPubMed
Signorelli, SS, Mazzarino, MC, Di Pino, Let al.. High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test. Vasc Med 2003 8, 15–19.CrossRefGoogle ScholarPubMed
Silverman, MD, Tumuluri, RJ, Davis, M, Lopez, G, Rosenbaum, JT & Lelkes, PIHomocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 2002 22, 587–592.CrossRefGoogle ScholarPubMed
Silvestro, A, Scopacasa, F, Oliva, G, de Cristofaro, T, Iuliano, L & Brevetti, GVitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication. Atherosclerosis 2002 165, 277–283.CrossRefGoogle ScholarPubMed
Simchon, S, Jan, KM & Chien, SInfluence of reduced red cell deformability on regional blood flow. Am J Physiol 1987 253, 898–903.Google ScholarPubMed
Smi, AJMedical treatment of peripheral vascular disease: are there new perspectives?. Vasa Supplemental 1992 34, 20–24.Google Scholar
Sommerfield, T & Hiatt, WROmega-3 fatty acids for intermittent claudication (Cochrane review). In The Cochrane Library issue 3, Chichester, UK: John Wiley & Sons, Ltd. 2004Google Scholar
Spark, JI, Robinson, JM, Gallavin, L, Gough, MJ, Homer-Vanniasinkam, S, Kester, RC & Scott, DJPatients with chronic critical limb ischemia have reduced total antioxidant capacity and impaired nutritional status. Eur J Vasc Endovasc Surg 2002 24, 535–539.Google ScholarPubMed
Stamler, JS, Osborne, JA, Jaraki, O, Rabbani, LE, Mullins, M, Singel, D & Loscalzo, JAdverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993 91, 308–318.CrossRefGoogle ScholarPubMed
Stark, AH & Madar, ZOlive oil as a functional food: epidemiology and nutritional approaches. Nutr Rev 2002 60, 170–176.CrossRefGoogle ScholarPubMed
Steinberg, DAntioxidants and atherosclerosis: a current assessment. Circulation 1991 84, 1420–1425.CrossRefGoogle ScholarPubMed
Steiner, M & Mower, RMechanism of action of vitamin E on platelet function. Ann N Y Acad Sci 1982 393, 289–299.CrossRefGoogle ScholarPubMed
Stringer, MD, Gorog, PG, Freeman, A & Kakkar, VVLipid peroxides and atherosclerosis. BMJ 1989 298, 281–284.CrossRefGoogle ScholarPubMed
Tabet, S & Berg, AO, for the US Preventive Services Task Force Screening for peripheral arterial disease. In Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force, pp. 63–66. Baltimore, MD: Williams & Wilkins. 1996Google Scholar
Taylor, LM Jr, DeFrang, RD, Harris, EJ Jr & Porter, JMThe association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg 1991 13, 128–136.CrossRefGoogle ScholarPubMed
Taylor, LM Jr, Moneta, GL, Sexton, GL, Schuff, RA & Porter, JMProspective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 1999 29, 8–21.CrossRefGoogle ScholarPubMed
Thies, F, Garry, JM, Yaqoob, P, Rerkasem, K, Williams, J, Shearman, CP, Gallagher, PJCalder, PC & Grimble, RFAssociation of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003 361, 477–485.CrossRefGoogle ScholarPubMed
Thorburn, A, Muir, J & Proietto, JCarbohydrate fermentation decreases hepatic glucose output in healthy subjects. Metabolism 1993 423, 780–785.CrossRefGoogle Scholar
Tornwall, ME, Virtamo, J, Haukka, JK, Aro, A, Albanes, D & Huttunen, JKProspective study of diet, lifestyle, and intermittent claudication in male smokers. Am J Epidemiol 2000 151, 892–901.CrossRefGoogle ScholarPubMed
Tsai, MY, Arnett, DK, Eckfeldt, JH, Williams, RR & Ellison, RCPlasma homocysteine and its association with carotid intimalmedial wall thickness and prevalent coronary heart disease: NHLBI Family Heart Study. Atherosclerosis 2000 151, 519–524.CrossRefGoogle ScholarPubMed
van den Berg, M, Franken, DG, Boers, GH, Blom, HJ, Jakobs, C, Stehouwer, CD & Rauwerda, JACombined vitamin B6 plus folic acid in young patients with atherosclerosis and hyperhomocysteinaemia. J Vasc Surg 1994 20, 933–940.CrossRefGoogle Scholar
van Tol, A, van der Gaag, MS, Scheek, LM, van Gent, T & Hendriks, HFChanges in postprandial lipoproteins of low and high density caused by moderate alcohol consumption with dinner. Atherosclerosis 1998 141, 101–103.CrossRefGoogle ScholarPubMed
Verhoef, P, Stampfer, MJ, Buring, JE, Gaziano, JM, Allen, RH, Stabler, SP, Reynolds, RDKok, FJ, Hennekens, CH & Willett, WCHomocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol 1996 143, 845–859.CrossRefGoogle ScholarPubMed
Vicaut, EOpposite effects of red blood cell aggregation on resistance to blood flow. J Cardiovasc Surg 1995 36, 361–368.Google ScholarPubMed
Violi, F, Criqui, M, Longoni, A & Castiglioni, CRelation between risk factors and cardiovascular complications in patients with peripheral arterial disease: results from the A.D.E.P. study. Atherosclerosis 1996 120, 25–35.CrossRefGoogle ScholarPubMed
Vogt, MT, Wolfson, SK & Kuller, LHSegmental arterial disease in the lower extremities: correlates of disease and relationship to mortality. J Clin Epidemiol 1993 46, 1267–1276.CrossRefGoogle ScholarPubMed
Wald, DS, Law, M & Morris, JKHomocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002 325, 1202–1206.CrossRefGoogle ScholarPubMed
Wall, RT, Harlan, JM, Harker, LA & Striker, GEHomocysteineinduced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980 18, 113–121.CrossRefGoogle Scholar
Wang, J, Dudman, NP & Wilcken, DEEffect of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells. Thromb Haemost 1993 70, 1047–1052.Google ScholarPubMed
Weiss, N, Keller, C, Hoffmann, U & Loscalzo, JEndothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 2002 7, 227–239.CrossRefGoogle ScholarPubMed
Welch, GN & Loscalzo, JHomocysteine and atherothrombosis. N Engl J Med 1998 338, 1042–1050.CrossRefGoogle ScholarPubMed
Westheim, AS, Brox, D & Selvaag, OAWD-alpha-tokoferol ved claudication intermittens (D-alpha-Tocopherol in intermittent claudication; article in Norwegian). Tidsskr Norske Laegeforen 1975 95, 13–15.Google Scholar
Williams, HT, Fenna, D & Macbeth, RAAlpha tocopherol in the treatment of intermittent claudication. Surg Gynecol Obstet 1971 132, 662–666.Google ScholarPubMed
Wilmink, AB, Welch, AA, Quick, CR, Burns, PJ, Hubbard, CS, Bradbury, AW & Day, NEDietary folate and vitamin B6 are independent predictors of peripheral arterial occlusive disease. J Vasc Surg 2004 39, 513–516.CrossRefGoogle ScholarPubMed
Woodcock, BE, Smith, E, Lambert, WH, Jones, WM, Galloway, JH, Greaves, M & Preston, FEBeneficial effect of fish oil on blood viscosity in peripheral vascular disease. Br Med J (Clin Res Ed) 1984 288, 592–594.CrossRefGoogle ScholarPubMed
World Health Organization Study Group Diet, Nutrition and Prevention of Chronic Diseases. Report of the Joint WHO/FAO Expert Consultation. WHO Technical Report Series, no. 916. Geneva: WHO.2003Google Scholar
Yataco, AR, Corretti, MC, Gardner, AW, Womack, CJ & Katzel, LIEndothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol 1999 83, 754–758.CrossRefGoogle ScholarPubMed